One of the firm’s early cases in the biotechnology industry was its successful representation of the inventor in the seminal Supreme Court case of Diamond v. Chakrabarty. In that case the Court held for the first time that a living, genetically-altered microorganism constituted patentable subject matter. The Chakrabarty decision spurred new interest in patents, particularly in the then-nascent biotechnology industry. Diamond v. Chakrabarty is widely credited as ushering in the biotechnology industry, spurring the formation of hundreds of new companies, the development of bioengineered plants and food, and the issuance of thousands of patents.
Please click here to view this landmark decision.